Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,873 total articles
Clene Inc. announced positive regulatory feedback from the FDA regarding its CNM-Au8 drug candidate for amyotrophic lateral sclerosis (ALS), with plans to submit a New Drug Application (NDA) under the accelerated approval pathway in Q3 2026. The company completed significant financing totaling over $35 million in early 2026, amended debt facilities…
Freshworks Inc. announced the launch of Freddy AI Agent Studio within its Freshservice platform, providing enterprises with a flexible, no-code solution to build and deploy custom AI agents that streamline service operations across IT, HR, finance, and facilities. This innovation aims to address the growing support gap for after-hours IT service by…
Gentherm announced it will showcase its WellSense™ technology at NeoCon 2026, highlighting its expansion into the Home and Office market. Leveraging decades of automotive and medical temperature management innovation, Gentherm is applying science-backed thermal and pneumatic comfort systems to furniture to enhance wellness, focus, relaxation, and r…
CVRx announced that Humana has issued a Medicare Advantage coverage policy for Barostim therapy, effective May 1, 2026. This marks the first coverage policy for Barostim by a major Medicare Advantage provider, covering patients meeting FDA-approved indications and those in the BENEFIT-HF trial. This follows other positive reimbursement developments…
Benitec Biopharma Inc. announced its third quarter 2026 financial results and provided an operational update on BB-301, its gene therapy candidate for Oculopharyngeal Muscular Dystrophy (OPMD). Interim clinical data shows durable and improving responses in patients treated with low and high doses of BB-301, with no severe adverse events. The compan…
Provident Bank released its 2026 Consumer Survey illustrating ongoing financial challenges faced by American households, including inflation, high interest rates, and a stagnant housing market. The survey reveals consumers are prioritizing basic necessities, managing debt more cautiously, and seeking financial guidance, though a gap exists in perce…
Microchip Technology Inc. announced the EX-423 Evacuated Miniature Crystal Oscillator (EMXO), a compact, low-power timing solution designed to offer high stability, accuracy, and long-term reliability. The device targets applications demanding ruggedized, accurate timing such as GPS/GNSS tracking, military radios, medical devices, and satellite com…
Keros Therapeutics reported a net loss of $23.7 million for Q1 2026, a significant decline from net income in Q1 2025, mainly due to the absence of license revenue recognized in the prior year from its agreement with Takeda. R&D expenses declined substantially as Takeda took over elritercept-related development and corporate restructuring costs dec…
MeiraGTx reported Q1 2026 financial and operational results including receipt of FDA Breakthrough Therapy Designation for AAV2-hAQP1, positive long-term data in radiation-induced xerostomia, and acquisition of botaretigene sparoparvovec (bota-vec) from Johnson & Johnson targeting X-linked retinitis pigmentosa. The company strengthened its balance s…
INmune Bio Inc. announced that its drug candidate XPro1595 (pegipanermin), a selective soluble TNF inhibitor targeting neuroinflammation, has received Fast Track designation from the FDA for the treatment of early Alzheimer's disease, including mild cognitive impairment and mild dementia due to Alzheimer’s. This designation supports expedited devel…
Chemomab Therapeutics reported its financial results for Q1 2026 and provided a corporate update focusing on its lead drug candidate nebokitug. The company presented new clinical and translational data from its Phase 2 SPRING trial showing nebokitug’s potential to modulate disease pathways in primary sclerosing cholangitis (PSC) and coexisting infl…
Kyverna Therapeutics, a late-stage clinical biopharmaceutical company specializing in cell therapies for autoimmune diseases, announced presentations at key investor conferences in May and June 2026. Their lead CAR T-cell therapy candidate, miv-cel, shows promise in treating B-cell-driven autoimmune disorders including stiff person syndrome and gen…
Xcel Brands announced a partnership with renowned dog behaviorist Cesar Millan to premiere his new pet product collection, Trust, Respect, Love by Cesar Millan, on QVC starting September 2026. The collection will include high-quality pet essentials inspired by Millan's dog training philosophy and is aimed at enhancing daily routines for dogs and th…
Standard Lithium Ltd., via its partnership Smackover Lithium with Equinor, announced completion of the U.S. Department of Energy's National Environmental Policy Act review with a Finding of No Significant Impact for the South West Arkansas lithium project. This approval removes a major regulatory hurdle, enabling the project to proceed toward a Fin…
Aduro Clean Technologies has joined the Utah Petroleum Association to engage with the oil and gas industry in Utah's Uinta Basin. This strategic membership supports Aduro's efforts to develop and pilot its Hydrochemolytic™ Technology for upgrading waxy paraffinic crude oils, aiming to improve transport and refinery compatibility. Recent bench-scale…
Micware Co., Ltd., a Japan-based software provider focused on automotive and mobility IT solutions, has announced the commencement of trading of its American Depositary Shares (ADSs) on the Nasdaq Global Market under the ticker symbol MWC. The listing marks Micware's entrance into the U.S. capital markets, supported by its strong OEM relationships …
ZenaTech, Inc. announces significant progress on its ZenaDrone 2000 heavy-lift interceptor drone, with manufacturing and system integration completed and initial flight testing scheduled for Q3 2026. The drone targets the growing $20 billion counter-drone defense market, offering gas-powered extended endurance, autonomous threat detection, and mult…
Corbus Pharmaceuticals has appointed Brent Pfeiffenberger, a seasoned pharma executive with extensive leadership roles at Bristol Myers Squibb and Century Therapeutics, to its Board of Directors. His expertise is expected to support Corbus’ ongoing development of its oncology treatment CRB-701 and obesity treatment CRB-913. The company anticipates …
SoundThinking, a NASDAQ-listed public safety tech company, announced David Jochim as their new Senior Vice President of TechnoLogic and Professional Services. Jochim is expected to strengthen operational discipline and grow the customer base for the TechnoLogic division, which supports the NYPD's Enterprise Case Management System and the CaseBuilde…
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company focused on novel cancer therapies, announced that its President and CEO, Angelos Stergiou, will participate in several upcoming investor conferences in May 2026, where corporate presentations and fireside chats will be conducted. The company highlighted its lead drug …
Algorhythm Holdings, Inc. (NASDAQ: RIME) announced record first quarter 2026 financial results driven by a 71% sequential and 1,851% year-over-year revenue increase to $2.4 million, primarily from scaling its SemiCab AI-powered logistics business. The company strengthened its cash position to nearly $11 million, reduced net loss by 42%, and returne…
Diginex Limited, a Nasdaq-listed sustainable RegTech company, disclosed significant expansion initiatives including a $1.5 billion all-share proposal to acquire AI-driven Resulticks, over $100 million in acquisitions since its 2025 IPO, a $40 million strategic reseller agreement, and $25.4 million in founder share purchase. These moves aim to evolv…
Synergy CHC Corp., a US consumer health and wellness company, reported first quarter 2026 financial results showing a revenue decline to $5.49 million from $8.17 million year-over-year, primarily due to non-recurrence of license revenue and out-of-stock issues. However, its functional beverage segment showed strong momentum with revenues exceeding …
Merlin, Inc. announced its new Merlin Pilot for Commercial Cargo product, part of the Condor family, which integrates AI-powered autonomous technology into commercial cargo aircraft. This system aims to enhance safety and operational efficiency amid growing global air freight demand and pilot shortages, with ongoing collaborations and progress towa…
La Rosa Holdings Corp. announced ongoing progress in its proposed transaction with Consensus Core Technologies, with expected definitive agreements anticipated within 45 to 60 days, subject to customary conditions. The transaction aims to create strategic opportunities for both companies. La Rosa Holdings is a real estate and PropTech company opera…
